Literature DB >> 31980396

German Version of SARC-F: Translation, Adaption, and Validation.

Michael Drey1, Uta Ferrari2, Marina Schraml2, Wolfgang Kemmler3, Daniel Schoene3, Anna Franke4, Ellen Freiberger4, Robert Kob4, Cornel Sieber4.   

Abstract

OBJECTIVES: Translation, adaptation, and validation of the German version of the SARC-F for community-dwelling older adults in Germany.
DESIGN: Cross-sectional. SETTING AND PARTICIPANTS: 117 community-dwelling outpatients with a mean age of 79.1 ± 5.2 years were included in the study; 94 (80.4%) of them were female. Sixty-three (53.8%) had a positive SARC-F score of ≥4 points. According to the definition of sarcopenia from the European Working Group on Sarcopenia in Older People (EWGSOP2), 8 patients (6.8%) were identified as sarcopenic and 57 (48.7%) as probable sarcopenic.
METHODS: According to EWGSOP2, probable sarcopenia was defined for patients with reduced hand grip strength (women: <16.0 kg; men: <27.0 kg) and/or impaired chair-rise time (both genders: >15 seconds). Patients with additional low skeletal muscle index were classified as sarcopenic (women: <5.5 kg/m2; men: <7.0 kg/m2). Translation and cultural adaption was composed of 7 different steps that were in general based on the guidelines put forward by the World Health Organization. Validation include test-retest and the inter-rater reliability (intraclass correlation coefficient) as well as internal consistency (Cronbach alpha). Furthermore, sensitivity, specificity, positive predictive value, and negative predictive value of the SARC-F were calculated. Receiver-operating characteristic analysis was performed to calculate the area under the curve.
RESULTS: The translated and culturally adapted version of the SARC-F for the German language has shown excellent inter-rater reliability and good test-retest reliability. The internal consistency is acceptable. Sensitivity (63%) and specificity (47%) for sarcopenia is low. For detecting patients with probable sarcopenia, the SARC-F in the German version has shown 75% sensitivity and 67% specificity. CONCLUSIONS AND IMPLICATIONS: Because of a low sensitivity for detecting sarcopenia but an acceptable sensitivity for identifying probable sarcopenia, the German version of the SARC-F is a suitable tool for case finding of probable sarcopenia.
Copyright © 2019 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  German; SARC-F; sarcopenia; screening; translation; validation

Mesh:

Year:  2020        PMID: 31980396     DOI: 10.1016/j.jamda.2019.12.011

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  12 in total

Review 1.  [Osteosarcopenia].

Authors:  M Drey; R Schmidmaier
Journal:  Internist (Berl)       Date:  2021-04-16       Impact factor: 0.743

2.  ROMANIAN TRANSLATION AND VALIDATION OF THE SARC-F QUESTIONNAIRE.

Authors:  A Gasparik; M B Demián; I Pascanu
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Apr-Jun       Impact factor: 0.877

3.  Longitudinal changes in muscle power compared to muscle strength and mass.

Authors:  Sabine Wiegmann; Dieter Felsenberg; Gabriele Armbrecht; Roswitha Dietzel
Journal:  J Musculoskelet Neuronal Interact       Date:  2021-03-01       Impact factor: 2.041

4.  Iron deficiency, fatigue and muscle strength and function in older hospitalized patients.

Authors:  Sophia Neidlein; Rainer Wirth; Maryam Pourhassan
Journal:  Eur J Clin Nutr       Date:  2020-09-08       Impact factor: 4.016

5.  SARC-F as a case-finding tool for sarcopenia according to the EWGSOP2. National validation and comparison with other diagnostic standards.

Authors:  Karolina Piotrowicz; Anna Głuszewska; Joanna Czesak; Małgorzata Fedyk-Łukasik; Ewa Klimek; Dolores Sánchez-Rodríguez; Anna Skalska; Barbara Gryglewska; Tomasz Grodzicki; Jerzy Gąsowski
Journal:  Aging Clin Exp Res       Date:  2021-01-28       Impact factor: 3.636

6.  Development of Taiwan Risk Score for Sarcopenia (TRSS) for Sarcopenia Screening among Community-Dwelling Older Adults.

Authors:  Tzyy-Guey Tseng; Chun-Kuan Lu; Yu-Han Hsiao; Shu-Chuan Pan; Chi-Jung Tai; Meng-Chih Lee
Journal:  Int J Environ Res Public Health       Date:  2020-04-21       Impact factor: 3.390

7.  Cross-cultural adaptation and validation of the Greek Version of the SARC-F for evaluating sarcopenia in Greek older adults.

Authors:  Maria Tsekoura; Evdokia Billis; Elias Tsepis; Sofia Lampropoulou; Charlotte Beaudart; Olivier Bruyere; Ozlem Yilmaz; Gullistan Bahat; John Gliatis
Journal:  J Musculoskelet Neuronal Interact       Date:  2020-12-01       Impact factor: 2.041

8.  Polish version of SARC-F to assess sarcopenia in older adults: An examination of reliability and validity.

Authors:  Roma Krzymińska-Siemaszko; Ewa Deskur-Śmielecka; Aleksandra Kaluźniak-Szymanowska; Arkadiusz Styszyński; Katarzyna Wieczorowska-Tobis
Journal:  PLoS One       Date:  2020-12-21       Impact factor: 3.240

9.  Sarcopenia and Malnutrition Screening in Female Osteoporosis Patients-A Cross-Sectional Study.

Authors:  Franca Genest; Dominik Rak; Elisa Bätz; Kerstin Ott; Lothar Seefried
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

10.  Polish Translation and Validation of the Mini Sarcopenia Risk Assessment (MSRA) Questionnaire to Assess Nutritional and Non-Nutritional Risk Factors of Sarcopenia in Older Adults.

Authors:  Roma Krzymińska-Siemaszko; Ewa Deskur-Śmielecka; Arkadiusz Styszyński; Katarzyna Wieczorowska-Tobis
Journal:  Nutrients       Date:  2021-03-24       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.